Intelligent bio solutions strengthens fda 510(k) package with new cybersecurity and performance data ahead of planned u.s. market launch

Fda response expected within six weeks; company remains focused on 2025 u.s. expansion fda response expected within six weeks; company remains focused on 2025 u.s. expansion

INBS Ratings Summary

INBS Quant Ranking